Peripartum cardiomyopathy: Review and practice guidelines

American Journal of Critical Care

Volumn 21, Issue 2, 2012, Pages 89-99

  Johnson Coyle, Leah ^a   Jensen, Louise ^a   Sobey, Alan ^b  

^a UNIVERSITY OF ALBERTA HOSPITAL   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CONGESTIVE CARDIOMYOPATHY; FEMALE; HUMAN; INCIDENCE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRACTICE GUIDELINE; PREGNANCY; PREGNANCY COMPLICATION; PROGNOSIS; PUERPERAL DISORDER; RECURRENT DISEASE; RISK FACTOR;

CARDIOMYOPATHY, DILATED; FEMALE; HUMANS; INCIDENCE; MAGNETIC RESONANCE IMAGING; PRACTICE GUIDELINES AS TOPIC; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PROGNOSIS; PUERPERAL DISORDERS; RECURRENCE; RISK FACTORS;

EID: 84857850152     PISSN: 10623264     EISSN: None     Source Type: Journal    
DOI: 10.4037/ajcc2012163     Document Type: Article

References (53)

1. Hibbard JU, Lindheimer M, Lang RM. A modified definition for peripartum cardiomyopathy and prognosis based on echocardiography. Obstet Gynecol. 1999;4(2):311-315.
2. Tidswell M. Peripartum cardiomyopathy. Crit Care Clin. 2004;20:777-788.
3. Sliwa K, Skudicky D, Bergemann A, Candy G, Puren A, Sareli P. Peripartum cardiomyopathy: analysis of clinical outcome, left ventricular function, plasma levels of cyto -kines and Fas/APO-1. J Am Coll Cardiol. 2000;35(3):701-705.
4. Pearson G, Veille J, Rahimtoola S, et al. Peripartum cardiomyopathy: National Heart, Lung, and Blood Institute and Office of Rare Diseases (National Institutes of Health) workshop recommendations and review. JAMA. 2000;283(9): 1183-1188.
5. Elkayam U, Tummala PP, Rao K, et al. Maternal and fetal outcomes of subsequent pregnancies in women with peripartum cardiomyopathy. N Engl J Med. 2001;344(21):1567-1571.
6. Sliwa K, Fett J, Elkayam U. Peripartum cardiomyopathy. Lancet. 2006;368(9536):687-693.
7. James P. A review of peripartum cardiomyopathy. Int J Clin Pract. 2004;58(4):363-365.
8. Fett JD, Christie LG, Carraway RD, Murphy JG. Five-year prospective study of the incidence and prognosis of peripartum cardiomyopathy at a single institution. Mayo Clin Proc. 2005;80(12):1602-1606.
9. Mielniczuk LM, Williams K, Davis DR, et al. Frequency of peripartum cardiomyopathy. Am J Cardiol. 2006;97(12): 1765-1768.
10. Ro A, Frishman W. Peripartum cardiomyopathy. Cardiol Rev. 2006:14(1):35-42.
11. Sliwa K, Tibazarwa K, Hilfiker-Kleiner D. Management of peripartum cardiomyopathy. Curr Heart Fail Rep. 2008;5(5): 238-244.
12. Demakis JG, Rahimtoola S, Sutton GC, et al. Natural course of peripartum cardiomyopathy. Circulation. 1971;44(6): 1053-1061.
13. Ramaraj R, Sorrell VL. Peripartum cardiomyopathy: causes, diagnosis, and treatment. Cleve Clin J Med. 2009;76(5): 289-296.
14. Elkayam U, Akhter MW, Singh H, et al. Pregnancy-associated cardiomyopathy: clinical characteristics and a comparison between early and late presentation. Circulation. 2005;111 (16):2050-2055.
15. Brar SS, Khan SS, Sandhu GK, et al. Incidence, mortality, and racial differences in peripartum cardiomyopathy. Am J Cardiol. 2007;100(2):302-304.
16. Hilfiker-Kleiner D, Sliwa K, Drexler H. Peripartum cardiomyopathy: recent insights in its pathophysiology. Trends Cardiovasc Med. 2008;18(5):173-179.
17. Abboud J, Murad Y, Chen-Scarabelli C, Saravolatz L, Scarabelli TM. Peripartum cardiomyopathy: a comprehensive review. Int J Cardiol. 2007;118(3):295-303.
18. Ntusi NB, Mayosi BM. Aetiology and risk factors of peripartum cardiomyopathy: a systematic review. Int J Cardiol. 2009;131(2):168-179.
19. Pearl W. Familial occurrence of peripartum cardiomyopathy. Am Heart J. 1995;129(2):421-422.
20. Moioli M, Menada MV, Bentivoglio G, Ferrero S. Peripartum cardiomyopathy. Arch Gynecol Obstet. 2010;281(2):183-188. doi:10.1007/s00404-009-1170-5.
21. Baruteau AE, Leurent G, Martins R, et al. Peripartum cardiomyopathy in the era of cardiac magnetic resonance imaging: first results and perspectives. Int J Cardiol. 2010; 144(1):143-145.
22. van Spaendonck-Zwarts KY, van Tintelen P, van Veldhuisen DJ, et al. Peripartum cardiomyopathy as a part of familial dilated cardiomyopathy. Circulation. 2010;121:2169-2175.
23. Burkett EL, Hershberger RE. Clinical and genetic issues in familial dilated cardiomyopathy. J Am Coll Cardiol. 2005; 45(7):969-981.
24. Elliott P, Andersson B, Arbustini E, et al. Classification of the cardiomyopathies: a position statement from the European Society of Cardiology Working Group on Myocardial and Pericardial Disease. Eur Heart J. 2008;29(2):270-276.
25. Goulet B, McMillan T, Bellet S. Idiopathic myocardial degeneration associated with pregnancy and especially the puerpernium. Am J Med Sci. 1937;194(2):185-199.
26. Melvin KR, Richardson PJ, Olsen EG, Daly K, Jackson G. Peripartum cardiomyopathy due to myocarditis. N Engl J Med. 1982;307(12):731-734.
27. Midei MG, DeMent SH, Feldman AM, Hutchins GM, Baughman KL. Peripartum myocarditis and cardiomyopathy. Circulation. 1990;81:922-928.
28. Felker GM, Jaeger CJ, Klodas E, et al. Myocarditis and long-term survival in peripartum cardiomyopathy. Am Heart J. 2000;140(5):785-791.
29. Ansari AA, Fett JD, Carraway RE, Mayne AE, Onlamoon N, Sundstrom JB. Autoimmune mechanisms as the basis for human peripartum cardiomyopathy. Clin Rev Allergy Immunol. 2002;23:301-324.
30. van Hoeven KH, Kitsis RN, Katz SD, Factor SM. Peripartum versus idiopathic dilated cardiomyopathy in young women -a comparison of clinical, pathological and prognostic factors. Int J Cardiol. 1993;40(1):57-65.
31. Hilfiker-Kleiner D, Kaminski K, Podewski E, et al. A cathepsin D-cleaved 16 kDa form of prolactin mediates postpartum cardiomyopathy. Cell. 2007;128(3):589-600.
32. Fett J, Ansara A, Sundstrom J, Combs G Jr. Peripartum cardiomyopathy: a selenium disconnection and an autoimmune connection. Int J Cardiol. 2002;86(2):311-316.
33. Cénac A, Simonoff M, Moretto P, Djibo A. A low plasma selenium is a risk factor for peripartum cardiomyopathy: a comparative study in Sahelian Africa. Int J Cardiol. 1992; 36(1):57-59.
34. Lampert MB, Hibbard J, Weinert L, Briller J, Lindheimer M, Lang RM. Peripartum heart failure associated with prolonged tocolytic therapy. Am J Obstet Gynecol. 1992;168(2):493-495.
35. Williams J, Mozurkewich E, Chilimigras J, Van De Ven C. Critical care in obstetrics: pregnancy-specific conditions. Best Pract Res Clin Obstet Gynaecol. 2008;22(5):825-846.
36. Sliwa K, Hilfiker-Kleiner D, Petrie MC, et al, Heart Failure Association of the European Society of Cardiology Working Group on Peripartum Cardiomyopathy. Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Working Group on Peripartum Cardiomyopathy. Eur J Heart Fail. 2010;12(8):767-778.
37. Pyatt JR, Dubey G. Peripartum cardiomyopathy: current understanding, comprehensive management review and new developments. Postgrad Med J. 2011;87(1023):34-39.
38. Lata I, Gupta R, Sahu S, Singh H. Emergency management of decompensated peripartum cardiomyopathy. J Emerg Trauma Shock. 2009;2(2):124-128.
39. Jessup M, Abraham W, Casey D, et al. 2009 Focused update: ACCF/AHA guidelines for the diagnosis and management of heart failure in adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the International Society for Heart and Lung Transplantation. J Am Coll Cardiol. 2009;53(15):1343-1382.
40. Ntusi NB, Chin A. Characterisation of peripartum cardiomyopathy by cardiac magnetic resonance imaging. Eur Radiol. 2009;19(6):1324-1325.
41. Carlin AJ, Alfirevic Z, Gyte ML. Interventions for treating peripartum cardiomyopathy to improve outcomes for women and babies. Cochrane Database Syst Rev. 2010(9): CD008589. doi:10.1002/14651858.CD008589.pub2.
42. Heart Failure Society of America. Executive summary: HFSA 2006 comprehensive heart failure practice guideline. J Card Fail. 2006;12(1):10-38.
43. Egan DJ, Bisanzo MC, Hutson HR. Emergency department evaluation and management of peripartum cardiomyopathy. J Emerg Med. 2009;36(2):141-147.
44. Arnold JM, Liu P, Demers C, et al; Canadian Cardiovascular Society. Canadian Cardiovascular Society consensus conference recommendation on heart failure 2006: diagnosis and management. Can J Cardiol. 2006;22(1):23-45.
45. McNamara DM, Holubkov R, Starling, RC, et al. Controlled trial of intravenous immune globulins in recent-onset dilated cardiomyopathy. Circulation. 2001;103:2254-2259.
46. Jahns BG, Stein W, Hilfiker-Kleiner D, Pieske B, Emons G. Peripartum cardiomyopathy-a new treatment option by inhibition of prolactin secretion. Am J Obstet Gynecol. 2008;199(4):e5-e6.
47. de Jong JS, Rietveld K, van Lochem LT, Bouma BJ. Rapid left ventricular recovery after cabergoline treatment in a patient with peripartum cardiomyopathy. Eur J Heart Fail. 2009;1(2): 220-222.
48. Keogh A, Macdonald P, Spratt P, Marshman D, Larbalestier R, Kaan A. Outcome in peripartum cardiomyopathy after heart transplantation. J Heart Lung Transplant. 1994;13(2):202-207.
49. Smith IJ, Gillham MJ. Fulminant peripartum cardiomyopathy rescue with extracorporeal membranous oxygenation. Int J Obstet Anesth. 2009;18(2):186-188.
50. Palanzo DA, Baer LD, El-Banayosy A, et al. Successful treatment of peripartum cardiomyopathy with extracorporeal membrane oxygenation. Perfusion. 2009;24(2):75-79.
51. Gavaert S, van Belleghem Y, Bouchez S, et al. Acute and critically ill peripartum cardiomyopathy and "bridge to" therapeutic options: a single center experience with intraaortic balloon pump, extra-corporeal membrane oxygenation and continuous-flow left ventricular assist devices. Crit Care. 2011;15(2):R93.
52. Rasmusson K, de Jong M, Doering L. Update on heart failure management. current understanding of peripartum cardiomyopathy. Prog Cardiovasc Nurs. 2007;22(4):214-216.
53. Chapa JB, Heiberger HB, Weinert L, Decara J, Lang RM, Hibbard JU. Prognostic value of echocardiography in peripartum cardiomyopathy. Obstet Gynecol. 2005;105(6):1303-1308.